Replies to post #1380 on AmStem Corporation (fka AMST)

[alexander77]

"The sale or issuance of a substantial number of shares may adversely affect the market price for our common stock.


The future sale of a substantial number of shares of our common stock in the public market, or the perception that such sales could occur, could significantly and negatively affect the market price for our common stock. We expect that we will likely issue a substantial number of shares of our capital stock in financing transactions in order to fund our operations and the growth of our business. Under these arrangements, we may agree to register the shares for resale soon after their issuance. We may also continue to pay for certain goods and services with equity, which
would dilute our current stockholders. Also, sales of the shares issued in this manner could negatively affect the market price of our stock."

http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=7206448
p37

[MinnieM]

The assets are higher than the liabilities, which is highly unusual for a company in this sector.

Once the anti-aging cream starts selling in the US the stock will most likely jump significantly. I highly doubt you'd want to enter at that point instead of at these levels. This is a perfect example of purchasing based on knowing what is coming.

And, you really don't want to be out once they announce the cirrhosis of the liver treatments are in the FDA approval process.

Take a look at others in the sector. I just looked at a few. Most have no income at all and I even looked at one trading over $2 which has liabilities many times over the assets.

Please find another in this sector that is in this price range whose financials are better. I'll grab some asap.

Have a good day all...I'm running out the door and will respond to anything else later. ;)






In Reply To 'alexander77'

According to their last Q-filing there are too much liabilities and current debt to comply with at PPS of this level.
You are right about the creams and all, the stock has potential, but the company needs to fulfill this potential first. This is now and at this point I would say a PPS of 0.02-0.04 would be more in line with the current true value of the company.